E Fund Management Co.,LTD.
E Fund Management Co., Ltd. is a privately owned investment manager based in Guangzhou, China, with additional offices in Beijing and Shanghai. Founded in April 2001, the firm specializes in managing equity and fixed income portfolios for institutions and high-net-worth individuals. E Fund also launches and manages mutual funds across various asset classes. The firm invests primarily in China's public equity and fixed income markets, employing a combination of top-down sector analysis and bottom-up stock selection. E Fund Management (HK) Co., Limited, a wholly owned subsidiary established in 2008, serves as the global investment platform, offering overseas investment products and focusing on RQFII-related businesses. E Fund has demonstrated substantial growth, managing assets close to RMB 430 billion, and has received numerous industry accolades for its disciplined management style and value investment philosophy. The firm consistently ranks among the top in industry performance and has been recognized in lists such as the Morningstar Best Fund Manager and the "Golden Bull" award for excellence in fund management.
Top Stages
14 past transactions
AccuPath
Venture Round in 2023
AccuPath is a high-tech group dedicated to enhancing human life and health via the use of modern materials & manufacturing science and technology.
GluBio Therapeutics
Series A in 2022
GluBio Therapeutics focuses on molecular glue-targeted protein degradation and provides a multi-dimensional protein degradation screening platform, an innovative target validation platform, a molecular glue rational design platform, and a proprietary library of highly active molecules.
Loctek Ergonomic Technology
Venture Round in 2021
Loctek Ergonomic Technology Corporation, established in 1998 and headquartered in Ningbo, China, specializes in the manufacturing and distribution of ergonomic products both domestically and internationally. The company's extensive product portfolio includes height-adjustable standing desks, collaborative media wall systems, monitor mounts, exercise equipment, accessories, and TV mount solutions. Additionally, Loctek offers smart office lift tables, ergonomic computer stands, children's study tables, and anti-static sitting health cars, catering to various industries such as IT, finance, government, education, and training sectors.
MicroPort CRM
Series C in 2021
MicroPort CRM is a leading company in the field of Cardiac Rhythm Management, headquartered in Clamart, France. As a subsidiary of MicroPort Scientific Corporation, it specializes in the design, development, and commercialization of advanced medical devices aimed at treating cardiac rhythm disorders and heart failure. The company's product portfolio includes cardiac pacemakers, implantable cardiac defibrillators, cardiac resynchronization systems, and ECG diagnostic solutions. MicroPort CRM's commitment to innovation is evident in its research and development efforts, which focus on improving treatment options for arrhythmias and enhancing patient outcomes. Its manufacturing facilities are located in Clamart, France, Saluggia, Italy, Santo Domingo, Dominican Republic, and Shanghai, China, ensuring a robust production capability to meet global demand.
Stemirna
Venture Round in 2021
Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science. The company currently has more than a dozen of independently-developed mRNA drug projects, focusing on the fields of mRNA-based personalized cancer vaccines, mRNA vaccines for infectious disease, protein defects diseases, and genetic diseases, providing cure and solutions for cancer and infectious diseases, better serving patients.
Hyperchain Technologies
Series C in 2021
Hyperchain Technologies Co., Ltd. is a prominent developer of enterprise-level blockchain solutions, headquartered in Hangzhou, China. Founded in 2016, the company leverages advanced container cloud technology and core algorithms to provide a range of applications, including digital billing, data trading systems, supply chain finance systems, and securities asset systems. Its offerings are distinguished by features such as consensus mechanisms, multi-level encryption, smart contract capabilities, and robust availability support. Hyperchain's technical foundation is recognized as a leading platform, having achieved top rankings in evaluations by various financial institutions. The company is also noted for its commitment to innovation, holding 28 patents related to blockchain technology and being among the first to pass important industry standards set by national authorities. With a highly skilled team, comprising a majority of technical experts, Hyperchain Technologies is well-positioned in the evolving blockchain landscape.
Jinqirui Biology
Series B in 2020
Jinqirui Biology is a biotechnology company that focuses on the research and development, manufacturing, production & sales of vitro diagnostics equipment and reagents.
InventisBio
Series D in 2020
InventisBio Inc. is a biotechnology company focused on discovering and developing innovative therapeutics for cancer and metabolic diseases. Founded in 2013 and based in Pudong, China, the company has developed a range of small molecule drug candidates targeting lung cancer, breast cancer, and gout. Among its notable products is D-0316, a third-generation EGFR-T790M tyrosine kinase inhibitor. InventisBio is also engaged in creating targeted immuno-oncology therapies that can be used in combination with existing treatments, such as PD-1 antibodies, to address various cancer indications. Co-founded by Dr. Yaolin Wang and a team of scientists with extensive experience in drug discovery at major pharmaceutical companies, InventisBio aims to provide effective therapies for significant health challenges.
MicroPort Medbot
Private Equity Round in 2020
MicroPort Medbot develops intelligent surgical solutions, focusing on minimal invasive surgery. Its product portfolio includes 3D electronic laparoscopy systems, laparoscopic and orthopedic surgical robots. Headquartered in Shanghai, China.
MicroPort EP
Private Equity Round in 2020
Shanghai MicroPort EP MedTech Co., Ltd. specializes in the development, manufacturing, and marketing of medical devices for cardiac electrophysiological interventional therapy. Founded in 2010 and based in Shanghai, the company provides a range of invasive medical devices designed for the treatment of electrophysiological diseases. Its product offerings include cardiac ablation catheters, diagnostic catheters, and advanced three-dimensional navigation systems. Notable products include the Columbus 3D EP navigation system, OptimAblate irrigation pump, and various RF generators and ablation catheters used in treating conditions such as tachyarrhythmia. MicroPort EP operates as a subsidiary of Shanghai MicroPort Medical (Group) Co., Ltd. and was previously known as Shanghai Wei Chuang Electrophysiology Medical Technology Co., Ltd. before its name change in April 2016.
MicroPort Orthopedics
Private Equity Round in 2020
MicroPort Orthopedics is a producer of orthopedic products and a member of the MicroPort Scientific Corporation family of companies. Its knee and hip implants are constantly being improved just as medical procedures. It operates as a start-up of an industry powerhouse. This is critical to achieving its goal of being the growing, innovation-driven company in orthopedics. Their top priority isn’t just to help surgeons get patients back to their feet.
Hongjitang
Venture Round in 2015
Hongjitang is a manufacturer of pediatric medicine, gynecological drugs, respiratory drugs, blood circulation pain relievers, neuro cancer drugs, genitourinary system drugs, and cardiovascular drugs. It also offers pills, powders, tablets, combinations, tinctures, gels, capsules, granules, decoctions, and oral liquids.
Linktop
Series B in 2015
Linktop is a manufacturer of healthcare and medical care products. By developing smart telehealth devices, Linktop hopes to make people's lives easier and healthier. It makes use of critical resources in research and development to create multi-functional and advanced medical and telemedicine solutions. Linktop is a researcher and provider of overall solutions for mobile positioning technology, mobile health management, and UC terminal medical treatment in the business field.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.